Life Science & Health Care

The health care intermediaries are facing seismic challenges like funding, medical costs, changing regulatory climate and effective solutions need to be tailored to health care systems.

The payer organisations must find paramount procedures to influence the evolution of health care industry.

The corporate leaders of health care institutions, medical centers and pharmacies must devise strategies to deliver value for patients, generate financial results and be competitive in local markets by enhancing portfolio of services and exploring channels to carefully grow in this segment.

India’s healthcare industry is driving the double digit growth in growing economy, escalating affluence among the populace, cultivating health awareness, shifting lifestyles resulting in higher incidence of chronic and lifestyle diseases, increased government expenditure and fast growing health insurance industry.

The Indian Biotechnology sector essays a strategic role in the economic development of the country by offering affordable healthcare services such as medicines and therapies while meeting the challenges to develope innovative products.

The concern in the health sector particular India’s children whose well being will determine the extent of much awaited demographic dividend.

The low income households are most vulnerable to problems like infant and maternal mortality, childhood nutrition, chronic adult diseases and financial burden to families.

The Government of India proposes to increase health spending from the current level of a little more than 1% of GDP to 2-3% but at the current rate of progress, India will not be able to achieve the Millennium Development Goals for health care.

The current pressures on the Life Sciences industry makes it increasingly important for Research & Development organizations positioning themself to execute and implement successfully at ultimately realizing the full benefits of their strategies.